IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

European Neuropsychopharmacology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

4.62

h-Index

2022-2023

 124

Rank

2022-2023

 2283

SJR

2022-2023

 1.442

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title European Neuropsychopharmacology
Abbreviation Eur. Neuropsychopharmacol.
Publication Type Journal
Subject Area, Categories, Scope Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)
h-index 124
Overall Rank/Ranking 2283
SCImago Journal Rank (SJR) 1.442
Impact Score 4.62
Publisher Elsevier
Country Netherlands
ISSN 0924977X, 18737862
Best Quartile Q1
Coverage History 1990-2022




About European Neuropsychopharmacology


European Neuropsychopharmacology is a journal covering the technologies/fields/categories related to Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2). It is published by Elsevier. The overall rank of European Neuropsychopharmacology is 2283. According to SCImago Journal Rank (SJR), this journal is ranked 1.442. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 124. The best quartile for this journal is Q1.

The ISSN of European Neuropsychopharmacology journal is 0924977X, 18737862. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Neuropsychopharmacology is cited by a total of 2015 articles during the last 3 years (Preceding 2022).


European Neuropsychopharmacology Impact IF 2022-2023


The Impact IF 2022 of European Neuropsychopharmacology is 4.62, which is computed in 2023 as per its definition. European Neuropsychopharmacology IF is increased by a factor of 0.28 and approximate percentage change is 6.45% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

European Neuropsychopharmacology Impact IF 2023 Prediction


Impact IF 2022 of European Neuropsychopharmacology is 4.62. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of European Neuropsychopharmacology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 4.62
2021 4.34
2020 3.66
2019 3.61
2018 4.32
2017 4.10
2016 4.52
2015 4.68
2014 4.44

European Neuropsychopharmacology h-index


  Table Setting

European Neuropsychopharmacology has an h-index of 124. It means 124 articles of this journal have more than 124 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




European Neuropsychopharmacology ISSN


The ISSN of European Neuropsychopharmacology is 0924977X, 18737862. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

European Neuropsychopharmacology Rank and SCImago Journal Rank (SJR)


The overall rank of European Neuropsychopharmacology is 2283. According to SCImago Journal Rank (SJR), this journal is ranked 1.442. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of European Neuropsychopharmacology by Year


Year SJR
2023/2024 Coming Soon
2022 1.442
2021 1.324
2020 1.603
2019 1.652
2018 1.911
2017 1.911
2016 2.085
2015 1.903
2014 2.209

Ranking of European Neuropsychopharmacology by Year


Year Ranking
2023/2024 Coming Soon
2022 2283
2021 2601
2020 2014
2019 1872
2018 1483
2017 1494
2016 1281
2015 1593
2014 1155

European Neuropsychopharmacology Publisher


Table Setting

European Neuropsychopharmacology is published by Elsevier. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1990-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of European Neuropsychopharmacology is Eur. Neuropsychopharmacol.. This abbreviation ('Eur. Neuropsychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in European Neuropsychopharmacology


If your research field is/are related to Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the European Neuropsychopharmacology?

European Neuropsychopharmacology latest impact IF is 4.62. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.68 (2015) and 3.61 (2019), respectively, in the last 9 years. Moreover, its average IS is 4.25 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the European Neuropsychopharmacology?

The European Neuropsychopharmacology has an SJR (SCImago Journal Rank) of 1.442, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.209 in 2014 and the lowest being 1.324 in 2021. Furthermore, the average SJR of the European Neuropsychopharmacology over the previous 9-year period stands at 4.25.


What's the latest h-index of the European Neuropsychopharmacology?

The latest h-index of the European Neuropsychopharmacology is 124.


Who's the publisher of the European Neuropsychopharmacology?

The European Neuropsychopharmacology is published by the Elsevier, with its country of publication being the Netherlands.


What's the current ranking of the European Neuropsychopharmacology?

The European Neuropsychopharmacology is currently ranked 2283 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1155 in 2014 and its lowest position of 2601 in 2021.


What's the abbreviation or short name for the European Neuropsychopharmacology?

The standard ISO4 abbreviation for the European Neuropsychopharmacology is Eur. Neuropsychopharmacol..


Is the "European Neuropsychopharmacology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

European Neuropsychopharmacology is classified as a journal that the Elsevier publishes.


What's the scope or major areas of the European Neuropsychopharmacology?

The European Neuropsychopharmacology encompasses the following areas:

  • Neurology
  • Neurology (clinical)
  • Pharmacology
  • Pharmacology (medical)
  • Psychiatry and Mental Health
  • Biological Psychiatry

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the European Neuropsychopharmacology?

The European Neuropsychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 0924977X, 18737862.


What's the best quartile of the European Neuropsychopharmacology?

The best quartile for the European Neuropsychopharmacology is Q1 (2022).


What's the coverage history of the European Neuropsychopharmacology?

The European Neuropsychopharmacology coverage history can be summarized as follows: 1990-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Milan Journal of Mathematics journal 3120 Birkhauser Verlag Basel 28 1.79
Journal of International Financial Management and Accounting journal 6179 Wiley-Blackwell Publishing Ltd 42 6.09
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
World Englishes journal 4960 Wiley-Blackwell 60 1.97
Journal of Sociolinguistics journal 5409 Wiley-Blackwell Publishing Ltd 61 1.96
Transnational Corporations journal 6120 UNCTAD United Nations Conference on Trade and Development 27 1.92
Libyan Studies journal 16122 Cambridge University Press 8 0.45
Population Review journal 17841 Sociological Demography Press 13 0.73
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01
Acta Periodica Technologica journal 19470 University of Novi Sad, Faculty of Technology 18 0.62

Check complete list




Year wise Impact Score (IS) of European Neuropsychopharmacology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 4.62
2021 4.34
2020 3.66
2019 3.61
2018 4.32
2017 4.10
2016 4.52
2015 4.68
2014 4.44



Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Lancet Psychiatry,The
Elsevier Ltd. | United Kingdom

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

JAMA Psychiatry
American Medical Association | United States

Evidence-Based Mental Health
BMJ Publishing Group | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Clinical Psychology Review
Elsevier Inc. | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Journal of the American Academy of Child and Adolescent Psychiatry
Elsevier Ltd. | United Kingdom

Lancet Healthy Longevity, The
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Biological Psychiatry

Lancet Psychiatry,The
Elsevier Ltd. | United Kingdom

Biological Psychiatry
Elsevier USA | United States

Translational Psychiatry
Nature Publishing Group | United Kingdom

Psychiatry Research
Elsevier Ireland Ltd | Ireland

Journal of Abnormal Psychology
American Psychological Association | United States

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier Inc. | United States

Dialogues in Clinical Neuroscience
Taylor and Francis Ltd. | United Kingdom

Bipolar Disorders
Blackwell Munksgaard | Denmark

npj Schizophrenia
Nature Publishing Group | United Kingdom

Brain Communications
Oxford University Press | United States

See All